Browsing Tag
Revumenib
1 post
Positive Data from Trials of Revumenib in Combination with Standard of Care Agents in Patients with Acute Leukemias
By Chris Wack Shares of Syndax Pharmaceuticals jumped 8% to $18 following the release of positive data from…
